I agree that this site is using cookies. You can find further informations here.
X
Romero-Laorden, N.
65  results:
Search for persons X
?
1

Treatment patterns and outcomes in metastatic castration-re..:

Olmos, D. ; Lorente, D. ; Alameda, D....
Annals of Oncology.  35 (2024)  5 - p. 458-472 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EP08.01-040 Peripheral Blood Cells as Predictors for Effica..:

Rogado, J. ; Pozo, F. ; Troule, K....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S355-S357 , 2022
Link: https://doi.org/10.1016/..
 
?
3

PD-0913 Local treatment to the primary tumor and PSA change..:

Lopez Campos, F. ; Lorente, D. ; Llacer-Pérez, C....
Radiotherapy and Oncology.  161 (2021)  - p. S755-S756 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Latest progress in molecular biology and treatment in genit..:

González-del-Alba, A. ; Arranz, J. Á. ; Bellmunt, J....
Clinical and Translational Oncology.  22 (2020)  12 - p. 2175-2195 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Immune-related adverse events predict the therapeutic effic..:

Rogado, J. ; Sánchez-Torres, J.M. ; Romero-Laorden, N....
European Journal of Cancer.  109 (2019)  - p. 21-27 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Predictive biomarker candidates to delineate efficacy of an..:

Romero-Laorden, N. ; Doger, B. ; Hernandez, M....
Clinical and Translational Oncology.  18 (2015)  1 - p. 1-8 , 2015
Link: https://doi.org/10.1007/..
 
?
7

Supplementary Material for: Is older age an independent pro..:

Toquero P ; Mondéjar R ; Romero-Laorden N...
doi:10.6084/m9.figshare.25012553.v1.  , 2024
Link: https://doi.org/10.6084/..
 
?
8

Supplementary Material for: Is older age an independent pro..:

Toquero P ; Mondéjar R ; Romero-Laorden N...
doi:10.6084/m9.figshare.25012553.v1.  , 2024
Link: https://doi.org/10.6084/..
 
?
9

Mutational profile of hormone-sensitive and castration-resi..:

Velasco Balanza, C. ; Iglesias Beiroa, A. ; Saavedra Centeno, M....
European Urology Open Science.  57 (2023)  - p. S141-S142 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Value of Early Circulating Tumor Cells Dynamics to Estimate..:

Lozano, R ; Lorente, D ; Aragon, IM...
issn:2072-6694.  , 2021
Link: http://hdl.handle.net/11..
 
?
11

Value of Early Circulating Tumor Cells Dynamics to Estimate..:

Lozano, R ; Lorente, D ; Aragon, IM...
Cancers, 2021, 13 (10).  , 2021
Link: https://repository.icr.a..
 
?
12

HSD3B1 (1245A>C) germline variant and clinical outcomes in ..:

Khalaf, D J ; Aragón, I M ; Annala, M...
http://hdl.handle.net/10668/15803.  , 2020
Link: http://hdl.handle.net/10..
 
?
13

Early Post-treatment Prostate-specific Antigen at 4 Weeks a..:

Rescigno, P ; Dolling, D ; Conteduca, V...
European urology oncology, 2020, 3 (2), pp. 176 - 182.  , 2020
Link: https://repository.icr.a..
 
?
14

Plasma Androgen Receptor and Docetaxel for Metastatic Castr..:

Conteduca, V ; Jayaram, A ; Romero-Laorden, N...
https://discovery.ucl.ac.uk/id/eprint/10056909/7/Attard_1-s2.0-S0302283818307395-main.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
15

Phase II pilot study of the prednisone to dexamethasone swi..:

Romero-Laorden, N ; Lozano, R ; Jayaram, A...
https://discovery.ucl.ac.uk/id/eprint/10065656/1/Attard_OA_s41416-018-0123-9.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
1-15